Please log in to view this page
Username
Password
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
